Katherine E. Brighty
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Cancer therapeutics and mechanisms 5
- Chemical Synthesis and Analysis 3
-
- Synthesis of heterocyclic compounds 2
- Asymmetric Synthesis and Catalysis 2
- Co-authors
- Thomas D. Gootz (5 shared papers)Paul R. McGuirk (3 shared papers)Chin H. Chen (2 shared papers)Deepak Dalvie (1 shared paper)S L Haskell (1 shared paper)Anis A. Khan (1 shared paper)Fausto G. Araujo (1 shared paper)Joyce A. Sutcliffe (1 shared paper)
- Journals
- Tetrahedron Letters (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)The Journal of Organic Chemistry (2 papers)Annual reports in medicinal chemistry (2 papers)Drug Metabolism and Disposition (1 paper)
- Partner nations
- United States
In The Last Decade
Katherine E. Brighty
18 papers receiving 516 citations
Peers
Comparison fields: 5 of 70
- Molecular Medicine 155
- Pharmacology 261
- Organic Chemistry 185
- Clinical Biochemistry 24
- Epidemiology 104
Countries citing papers authored by Katherine E. Brighty
This map shows the geographic impact of Katherine E. Brighty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Brighty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Brighty more than expected).
Fields of papers citing papers by Katherine E. Brighty
This network shows the impact of papers produced by Katherine E. Brighty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Brighty. The network helps show where Katherine E. Brighty may publish in the future.
Co-authors
The 25 scholars most cited alongside Katherine E. Brighty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 159 | |
| 2 | 1997 | 115 | |
| 3 | 2000 | 74 | |
| 4 | 1994 | 39 | |
| 5 | 2000 | 29 | |
| 6 | 1999 | 24 | |
| 7 | 1996 | 23 | |
| 8 | 1991 | 15 | |
| 9 | 2011 | 14 | |
| 10 | 1993 | 14 | |
| 11 | 1993 | 13 | |
| 12 | 1981 | 11 | |
| 13 | 1980 | 7 | |
| 14 | 1988 | 5 | |
| 15 | 2010 | 5 | |
| 16 | 2010 | 3 | |
| 17 | 1996 | 2 | |
| 18 | 1997 | 1 |
About Katherine E. Brighty
Katherine E. Brighty is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Molecular Medicine and Oncology, having authored 18 papers that have together received 553 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Resistance in Bacteria (5 papers), Cancer therapeutics and mechanisms (5 papers), Chemical Synthesis and Analysis (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Synthesis of heterocyclic compounds (2 papers), Fluorine in Organic Chemistry (2 papers) and Asymmetric Synthesis and Catalysis (2 papers). The work is most often cited by research in Molecular Medicine (155 citations), Pharmacology (261 citations), Organic Chemistry (185 citations), Clinical Biochemistry (24 citations) and Epidemiology (104 citations). Katherine E. Brighty has collaborated with scholars based in United States. Frequent co-authors include Thomas D. Gootz, Paul R. McGuirk, Chin H. Chen, Deepak Dalvie, S L Haskell, Anis A. Khan, Fausto G. Araujo, Joyce A. Sutcliffe, Jack S. Remington and Manoj C. Desai. Their work appears in journals such as Tetrahedron Letters, Bioorganic & Medicinal Chemistry Letters, The Journal of Organic Chemistry, Annual reports in medicinal chemistry and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.